当前位置:  首页 >> 最新重要论文

必赢合作伙伴

CD146 bound to LCK promotes TCR signaling and anti-tumor immune response in mice, J Clin Invest, 9 Sep 2021

发布时间:2021年09月07日

本文地址:http://141.293tyc.com/zxzylw/202109/t20210913_6200652.html
文章摘要:百合实时返水3.0%,希望你不要想歪了时候眼中却是充满了炙热 ,这是什么人还是你cào控。

Journal of clinical investigation, 7 September, 2021, DOI:必赢合作伙伴

CD146 bound to LCK promotes TCR signaling and anti-tumor immune response in mice

Hongxia Duan, Lin Jing, Xiaoqing Jiang, Yanbin Ma, Daji Wang, Jianquan Xiang, Xuehui Chen, Zhenzhen Wu, Huiwen Yan, Junying Jia, Zheng Liu, Jing Feng, Mingzhao Zhu, and Xiyun Yan

Abstract

Initiation of T cell receptor (TCR) signaling involves the activation of the tyrosine kinase LCK; however, it is currently unclear how LCK is recruited and activated. Here, we have identified the membrane protein CD146 as an essential member of the TCR network for LCK activation. CD146 deficiency in T cells substantially impaired thymocyte development and peripheral activation, both of which depend on TCR signaling. CD146 was found to directly interact with the SH3 domain of coreceptor-free LCK via its cytoplasmic domain. Interestingly, CD146 was found to be present in both monomeric and dimeric forms in T cells, with the dimerized form increasing after TCR ligation. Increased dimerized CD146 recruited LCK and promoted LCK autophosphorylation. In tumor models, CD146 deficiency dramatically impaired the anti-tumor response of T cells. Together, our data reveal a previously unrecognized LCK activation mechanism for TCR initiation. We also underscore a rational intervention based on CD146 for tumor immunotherapy.

文章链接:http://www.ilj.70sbvip.com/articles/view/148568

相关报道:http://141.293tyc.com/kyjz/zxdt/202109/t20210913_6200616.html

 

 

    附件下载:
U宝摇钱树 云盈平台app 永利直营网站 澳门盈丰平台 瑞丰国际博彩官方网站
立博娱乐城在线 水舞间娱乐游戏手机版 银河赌场 皇浦指定开户 申博游戏美女荷官
腾博会怎么玩 世界杯足彩app 奔驰合作伙伴 澳门伯爵直营网址 香港正版资料
易胜娱乐线 伟德游戏忘记密码 申博网上娱乐厅 澳门银河星际登入 申博在线管理网登入